VF
ACOR

Virtu Financial’s Acorda Therapeutics ACOR Stock Holding History

Virtu Financial’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,071
Closed -$6K – 2409
2022
Q3 		$6K Sell
1,071
-6,195
-85% -$51.8K ﹤0.01% 1575
2022
Q2 		$68K Buy
+7,266
New +$129K 0.01% 1041
2021
Q3 		– Sell
-506
Closed -$48K – 2159
2021
Q2 		$48K Buy
+506
New +$44.3K ﹤0.01% 1340
2020
Q3 		– Sell
-224
Closed -$20K – 1672
2020
Q2 		$20K Buy
+224
New +$23.7K ﹤0.01% 1138

Other funds holding ACOR

DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
SC
Saltoro Capital Dallas, Texas $30K AUM 24.79% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Virtu Financial's ACOR Position: Q4 2022 in Review

Virtu Financial sold out of Acorda Therapeutics (ACOR) in Q4 2022, closing a stake of 1,071 shares — an estimated $6K sold.

Virtu Financial first reported a position in ACOR in Q2 2020 and held it in 4 quarters. The position peaked at $68K in Q2 2022. 34 funds tracked by Wall St. Rank hold ACOR as of Q4 2022.

  • Virtu Financial reported no remaining Acorda Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Virtu Financial sold 1,071 Acorda Therapeutics shares in Q4 2022, an estimated $6K.
  • Virtu Financial first reported a position in Acorda Therapeutics in Q2 2020 and held it in 4 quarters.
  • Virtu Financial's Acorda Therapeutics position peaked at $68K in Q2 2022.
  • 34 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2022.

Based on Virtu Financial's 13F filing for Q4 2022, filed 15 Feb 2023.